London, Jan 30 (ANI): In a clinical trial, scientists from Northwestern University's Feinberg School of Medicine have showed that stem cell transplantation could reverse the neurological dysfunction of early-stage multiple sclerosis patients.

For the study, the researchers transplanted the patients' own immune stem cells into their bodies and thereby "resetting" their immune systems.

"This is the first time we have turned the tide on this disease," Lancet quoted principal investigator Richard Burt, M.D. chief of immunotherapy for autoimmune diseases at the Feinberg School, as saying.

It was found that the patients in the small phase I/II trial continued to improve for up to 24 months after the transplantation procedure and then stabilized.

They experienced improvements in areas in which they had been affected by multiple sclerosis including walking, ataxia, limb strength, vision and incontinence.

Multiple sclerosis (MS) is an autoimmune disease in which the immune system attacks the central nervous system. In its early stages, the disease is characterized by intermittent neurological symptoms, called relapsing-remitting MS.

During this time, the person will either fully or partially recover from the symptoms experienced during the attacks.
Click here for the rest.

This is really good news for anybody here with MS. Stem cells are really turning into the cure-all of damages. The next 15 years of medicine and science should be pretty wild.